Angiogenic balance and diagnosis of pre-eclampsia: Selecting the right VEGF receptor

Journal of Human Hypertension

Volumn 26, Issue 3, 2012, Pages 205-206

  Jha, V ^a   Aggarwal, P K ^a   Chandel, N ^a   Jain, V ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PLACENTAL GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; AREA UNDER THE CURVE; DIAGNOSTIC VALUE; ECLAMPSIA; HUMAN; LETTER; MATERNAL HYPERTENSION; PATHOGENESIS; PREECLAMPSIA; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PREGNANCY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84857052736     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2011.89     Document Type: Letter

References (9)

1. Rath G, Tripathi R. VEGF and its soluble receptor VEGFR-2 in hypertensive disorders during pregnancy: the Indian scenario. J Hum Hypertens 2012; 26(3): 196-204.
2. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S et al. Excess placental soluble fms-like tyrosine kinase 1 (s Flt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649-658. (Pubitemid 36278583)
3. Tsatsaris V, Goffin F, Munaut C, Brichant JF, Pignon MR, Noel A et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endo-crinol Metab 2003; 88: 5555-5563. (Pubitemid 37452769)
4. Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672-683. (Pubitemid 38364626)
5. Lim JH, Kim SY, Park SY, Yang JH, Kim MY, Ryu HM. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors. Obstet Gynecol 2008; 111: 1403-1409.
6. Verlohren S, Galindo A, Schlembach D, Zeisler H, Herraiz I, Moertl MG et al. An automated method for the determi-nation of the s Flt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 2010; 202: 161e161-161e111.
7. Polliotti BM, Fry AG, Saller DN, Mooney RA, Cox C, Miller RK. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol 2003; 101: 1266-1274. (Pubitemid 36694354)
8. De Vivo A, Baviera G, Giordano D, Todarello G, Corrado F, D'anna R. Endoglin, Pl GF and s Flt-1 as markers for predicting pre-eclampsia. Acta Obstet Gynecol Scand 2008; 87: 837-842.
9. Aggarwal PK, Chandel N, Jain V, Jha V. The relation-ship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia. J Hum Hypertens 2011 (e-pub ahead of print 31 March 2011; doi:10.1038/jhh.2011.29).